Bristol-Myers Squibb Company (BMY)
Bristol-Myers Squibb Company (BMY) is a Drug Manufacturers - General company in the Healthcare sector listed on the NYSE.
As of Oct 23, 2026: market cap $129B; returns 1 day -2.4%, 1 week +2.9%, 1 year +40.3%.
Bristol-Myers Squibb Company (BMY) is a global biopharmaceutical company primarily focused on the discovery, development, manufacturing, and sale of proprietary medicines across key therapeutic areas including Oncology, Hematology, Immunology, Cardiovascular, and Neuroscience.
Groups BMY belongs to
- Dividend Payers
- 25-Year Dividend Payers
- S&P 500
- Pharmaceuticals
- Biopharmaceutical
- Healthcare
- Oncology
- Hematology
- Rheumatoid Arthritis
- Immunotherapy
- Cardiovascular Therapies
- Biotechnology
- Autoimmune Diseases
- Neuroscience
BMY financial model: income statement, cash flow and balance sheet